A Thread Lift Is an Eighteen-Month Rental, Sold With Permanent-Sounding Photographs

What actually happens

A thread lift places barbed absorbable sutures — most commonly polydioxanone, the same polymer used in surgical suture — into the subcutaneous plane through a needle or cannula. The barbs or cones grip tissue in one direction. The practitioner then pulls the thread along its axis, gathering the tissue upward, and anchors it. The entry points are punctures rather than incisions, the procedure takes under an hour, and the effect is visible immediately.

Two things are claimed for it. The first is mechanical: the thread physically repositions tissue and holds it while it is there. That is straightforwardly true and is why the result appears on the table.

The second is the one that carries most of the marketing weight — that as the polymer hydrolyses over months, the localised inflammatory response deposits collagen along the thread track, leaving a durable improvement after the suture itself is gone. This is usually described as a collagen legacy or a scaffold effect. The mechanism is biologically plausible. What it lacks is evidence proportionate to how confidently it is asserted, and the distinction between plausible and demonstrated is the whole subject of this article.

Polydioxanone typically hydrolyses over roughly six months, with the mechanical support degrading before it disappears entirely. Whatever holds after that is the legacy effect, and its magnitude is exactly the contested question.

The evidence, or the absence of it

In 2018 a group of plastic surgeons repeated a review first done in 2006, which had concluded that thread lifting was in its infancy but had great potential. Eleven years on, they wanted to know what had been added.

Their search returned 188 articles. After removing duplicates, open surgical procedures, review articles, case reports, letters, and studies of non-barbed sutures, twelve papers remained — seven more than the five available in 2006. Their conclusion, published in Plastic and Reconstructive Surgery, was that within the past decade little or no substantial evidence had been added to the peer-reviewed literature to support or sustain the earlier promise, in terms of either efficacy or safety.

That is an unusually direct thing for a systematic review to say, and it deserves to be held in view against the volume of marketing the procedure now carries. Threads are one of the most heavily promoted treatments in aesthetics and one of the least well evidenced. Those two facts coexist because the procedure is quick, the margin is high, the effect is immediately photographable, and — crucially — it does not require the training a surgical alternative would.

What this does not mean is that threads do nothing. The immediate mechanical effect is not in dispute. What is in dispute is duration, the size of any residual benefit, and how the complication rate varies with who is holding the cannula.

The complication list, with numbers

Here the literature is more useful, because a meta-analysis pooled 26 studies specifically to estimate how often things go wrong.

Swelling was the most common finding, at a pooled incidence of 35%. Then skin dimpling at 10%, paraesthesia at 6%, thread visibility or palpability at 4%, infection at 2% and thread extrusion at 2%.

Dimpling and extrusion are the two worth understanding properly, because they are the ones that are visible to other people. Dimpling is a puckering at the point where a barb has gripped too superficially, and at one in ten it is not a rare event. Extrusion is a thread end working its way out through the skin. Neither is dangerous. Both are conspicuous, both require intervention, and both are strongly technique-dependent — which is the mechanism by which injector experience translates into outcome.

Two subgroup findings sharpen the picture. Absorbable threads carried substantially lower risk than non-absorbable ones: paraesthesia 3.1% against 11.7%, extrusion 1.6% against 7.6%. And patients over 50 had markedly higher rates of dimpling — 16% against 5.6% — and infection, at 5.9% against 0.7%. That second finding matters because it points the same way as the tightening-device evidence: the population with the most laxity, and therefore the most reason to want the procedure, is the population in which it goes wrong most often.

Why the before-and-after photograph oversells

The single most useful number in the meta-analysis is the one about satisfaction, and it is not a complication rate.

Pooled satisfaction immediately after treatment was 98%. At six months it was 88%. That is a statistically significant decline measured inside a window that is still early relative to the marketed duration of the result.

Think about what produces that curve. Immediately after a thread lift the tissue has been mechanically pulled and is also swollen from the trauma of insertion. Swelling in the mid-face and along the jaw is volumising — it fills, it smooths, and it reads in a photograph as a lift. The image taken at the one-week or two-week follow-up, which is when clinics naturally photograph, captures the mechanical result plus the oedema. Both fade, on different schedules.

This is not necessarily deliberate deception. It is the ordinary consequence of photographing when the patient happens to be in the clinic. But it means the standard before-and-after pair systematically documents the best moment rather than the settled result, and no reasonable patient reading it would know that.

The practical response is to ask for photographs at six and twelve months rather than at two weeks, from that practitioner's own patients. A clinic that has them will show you. A clinic that only has early images has told you what it tracks. Photographing yourself monthly at fixed angles is the other half of that, and it is the only way you will know what you actually got.

Where threads genuinely fit

None of the above makes this a procedure to avoid. It makes it a procedure with a narrow correct indication that is routinely stretched.

The honest fit is early-to-moderate laxity in a younger patient — broadly thirties to forties — with good skin quality, minimal excess tissue, and a specific vector complaint: a mid-face that has descended slightly, a jawline losing definition, a brow tail dropping. Someone in that position gets a real mechanical improvement with modest downtime, and the age-related complication data is in their favour rather than against them.

The stretched indication is the person with substantial laxity and genuine excess skin who has been told threads are the non-surgical alternative to a facelift. They are not. Threads gather tissue; they do not remove it, and gathering tissue that is already surplus tends to produce bunching rather than contour. This is the patient in whom dimpling is most likely, satisfaction falls fastest, and the money would have been better spent either on a course of energy-based treatment or on the surgery itself.

The other honest use is as an adjunct rather than a headline — combined with volume restoration or an energy device, where the thread supplies vector and something else supplies quality. That is how a lot of experienced practitioners actually use them, and it is a very different proposition from threads as a standalone lift.

What you can control is who does it. The complication profile is technique-dependent to an unusual degree, so plane, vector planning and anatomical knowledge are the whole game, and this is not a procedure to buy on price. The Derm Visit Prep tool is a reasonable way to arrive with the right questions — how many they perform, what thread type, what their own dimpling rate is, and what happens if a thread extrudes.

Around the procedure, and instead of it

Aftercare is mostly restraint. Sleeping on your back, avoiding wide mouth movements, chewing soft food and skipping facial massage or dental work for a few weeks are standard because the barbs need time to be held by tissue rather than by tension. Bruising and swelling at the entry points are expected. Something bland and reparative over the puncture sites is reasonable — La Roche-Posay Cicaplast Baume B5+, Bioderma Cicabio Cream or Avène Cicalfate+ Restorative Protective Cream are the products designed for exactly this, and none of them influence the lift.

The more important question is what belongs in the plan alongside or instead. Threads address position. They do nothing for skin quality, and a repositioned face with thin, sun-damaged, crepey skin still reads as tired. The topical work that improves quality is unglamorous and evidenced: a retinoid over months, and daily photoprotection to stop degrading the collagen you have. The Ordinary Retinol 0.5% in Squalane and CeraVe Resurfacing Retinol Serum are two straightforward entry points, and ↗our retinol ranking covers the category properly. ↗The retinol entry sets out what the evidence supports.

And the framing that makes the decision easier: price it as a rental. If the mechanical effect runs roughly twelve to eighteen months and any legacy benefit is modest and contested, then the honest comparison is not one thread lift against one facelift. It is a thread lift every eighteen months, indefinitely, against a single durable intervention — or against a course of energy-based treatment, or against doing nothing yet and spending the money on skin quality until the anatomy actually warrants surgery. All of those are defensible. Only one of them is usually presented as the obvious middle option, and it happens to be the one with the least evidence behind it.